Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer

The panel surveys the clinical trial landscape and emerging therapeutic strategies for patients with recurrent endometrial cancer, particularly those who have progressed on frontline checkpoint inhibitor–based therapy.